Ipragliflozin L-Proline

Ipragliflozin L-Proline

Product Details:

  • Molecular Weight 408.87 g/mol
  • Boiling point Not Applicable
  • Structural Formula Not Provided
  • Heavy Metal (%) Not Provided
  • Storage Store in a cool dry place away from direct sunlight,
  • HS Code Not Provided
  • Particle Size Not Provided
  • Click to View more
X

Ipragliflozin L-Proline Price And Quantity

Ipragliflozin L-Proline Product Specifications

  • Pharmaceutical Intermediate
  • Not Provided
  • Not Provided
  • Store in a cool dry place away from direct sunlight
  • Not Provided
  • Not Provided
  • White to off-white powder
  • Not Applicable
  • 408.87 g/mol
  • Ipragliflozin L-Proline
  • C21H25ClO6
  • Not Provided
  • Not Provided
  • Solid
  • Slightly soluble in water
  • Not Applicable
  • Not Provided
  • Ipragliflozin L-Proline
  • Odorless
  • 2 years when stored properly
  • Not Provided
  • Medical Grade
  • Not Provided
  • NO
  • White to off-white
  • Treatment for diabetes by inhibiting sodium-glucose co-transporter 2 (SGLT2)
  • Not Applicable

Product Description

CAS number : 951382-34-6 Properties : Synonym L-Proline compd. with (1S)-1,5-anhydro-1-C-[3-(benzo[b]thien-2-ylmethyl)-4-fluorophenyl]-D-glucitol (1: 1) Molecular Formula C21H21FO5S.C5H9NO2 Molecular Weight 519.58 Specifications AVAILABLE ON REQUEST Packing EXPORT WORTHY PACKING Availability FOR R&D PURPOSE ONLY

FAQs of Ipragliflozin L-Proline:


Q: What is the appearance and color of Ipragliflozin L-Proline?

A: Ipragliflozin L-Proline appears as a white to off-white powder.

Q: How should Ipragliflozin L-Proline be stored?

A: It should be stored in a cool, dry place away from direct sunlight.

Q: What is the molecular formula and molecular weight of Ipragliflozin L-Proline?

A: The molecular formula is C21H25ClO6, and the molecular weight is 408.87 g/mol.

Q: Is Ipragliflozin L-Proline poisonous?

A: No, Ipragliflozin L-Proline is not poisonous.

Q: What is the usage of Ipragliflozin L-Proline?

A: Ipragliflozin L-Proline is used for the treatment of diabetes by inhibiting sodium-glucose co-transporter 2 (SGLT2).

Other Products in 'Active Pharmaceutical Ingredient' category



Back to top